Skip to content
  • Exoskeleton
  • Resources
    • Clinical Evidence
    • Spinal Cord Injury
    • Testimonials
    • Frequently asked questions
  • Our Company
    • About Us
    • Events
    • Team
    • Collaborators
    • Distributors
    • Work with Us
  • BLOG
  • Contact Us
Menu
  • Exoskeleton
  • Resources
    • Clinical Evidence
    • Spinal Cord Injury
    • Testimonials
    • Frequently asked questions
  • Our Company
    • About Us
    • Events
    • Team
    • Collaborators
    • Distributors
    • Work with Us
  • BLOG
  • Contact Us
SOLICITAR DEMO
  • EN
  • January 6, 2019

La Vanguardia – EIT Health will invest 86M on European health innovation projects ’19

La Vanguardia journal mentions ABLE Human Motion as one of the main projects EIT Health will invest on during 2019.

Find out more about the article on the link below:

https://www.lavanguardia.com/monograficos/eit-health/eit-health-invertira-86-millones-de-euros-en-proyectos-europeos-de

Categories:

  • News
|

Share:

|
See all news

Recent news

Clinical experience with the ABLE Exoskeleton in the Public Health Systems of 4 Autonomous Communities, 26th SERMEF Symposium

ABLE Exoskeleton is Approved for New Indications: Disease-Agnostic Approach

ABLE Exoskeleton: New Features Enhancing Neurorehabilitation for Patients and Therapists

2025 ABLE’s main achievements

View all news

Blog categories

With the support of:

ABLE HUMAN MOTION S.L.

C/ Marie Curie 8-14, 08042 Barcelona

hello@ablehumanmotion.com

93 189 25 94

 

Sign up for our Newsletter
  • Exoskeleton
  • About Us
  • Resources
  • Testimonials
  • Blog
  • Contact Us
  • Exoskeleton
  • About Us
  • Resources
  • Testimonials
  • Blog
  • Contact Us
  • Exoskeleton
  • Resources
    • Clinical Evidence
    • Spinal Cord Injury
    • Testimonials
    • Frequently asked questions
  • Our Company
    • About Us
    • Events
    • Team
    • Collaborators
    • Distributors
    • Work with Us
  • BLOG
  • Contact Us
Follow us
Instagram Youtube

ABLE Human Motion ® 2026 | All rights reserved | Privacy Policy | Cookies Policy | General Terms & Conditions